 |
Previous Article | Next Article 
The Journal of Neuroscience, August 15, 2001, 21(16):5864-5870
Altered Processing of Pro-Orphanin FQ/Nociceptin and
Pro-Opiomelanocortin-Derived Peptides in the Brains of Mice Expressing
Defective Prohormone Convertase 2
Richard G.
Allen2,
Bonnie
Peng1,
Michael J.
Pellegrino2,
Emilie D.
Miller3,
David K.
Grandy4,
James R.
Lundblad5,
Carrie L.
Washburn2, and
John E.
Pintar1
1 Neuroscience and Cell Biology, University of Medicine
and Dentistry of New Jersey-Robert Wood Johnson Medical
School, Piscataway, New Jersey 08854, and 2 Center
for Research on Occupational and Environmental Toxicology,
3 Neuroscience Graduate Program, and Departments of
4 Physiology and Pharmacology and 5 Molecular
Medicine, Oregon Health Sciences University, Portland, Oregon 97201
The bioactivity of neuropeptides can be regulated by a variety of
post-translational modifications, including proteolytic processing.
Here, gene-targeted mice producing defective prohormone convertase 2 (PC2) were used to examine the post-translational processing of two
neuroendocrine prohormones, pro-opiomelanocortin (POMC) and
pro-orphanin FQ (pOFQ)/nociceptin (N), in the brain. Reversed-phase
HPLC and gel-exclusion chromatography were combined with
specific radioimmunoassays to analyze the processing patterns of these
two prohormones in the hypothalamus and the amygdala. In the case of
POMC, the lack of PC2 activity completely prevented carboxy-shortening
of -endorphins and greatly diminished conversion of -lipotropin
to -lipotropin and -endorphin. Although conversion of
-lipotropin to -endorphin decreased, the lack of PC2 activity caused an increase in -lipotropin and -endorphin levels in the mutant animals, but no increases in POMC or biosynthetic intermediates were seen. The extent of OFQ/N production was significantly lower in
PC2-deficient mice and there was an accumulation of relatively large
amounts of pOFQ/N and biosynthetic intermediates. These results
demonstrate that PC2 is directly involved in the biogenesis of two
brain neuropeptides in vivo and suggest that the
specific prohormone and cellular context influences neuropeptide
processing by PCs.
Key words:
neuropeptide; proteolytic processing; pro-orphanin
FQ/nociceptin; POMC; PC2; gene-targeting
Copyright © 2001 Society for Neuroscience 0270-6474/01/21165864-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
L. Funkelstein, T. Toneff, C. Mosier, S.-R. Hwang, F. Beuschlein, U. D. Lichtenauer, T. Reinheckel, C. Peters, and V. Hook
Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, {beta}-Endorphin, and {alpha}-MSH, Illustrated by Protease Gene Knockout and Expression
J. Biol. Chem.,
December 19, 2008;
283(51):
35652 - 35659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Scamuffa, F. Calvo, M. Chretien, N. G. Seidah, and A.-M. Khatib
Proprotein convertases: lessons from knockouts
FASEB J,
October 1, 2006;
20(12):
1954 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Humphreys
{gamma}-MSH, sodium metabolism, and salt-sensitive hypertension
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2004;
286(3):
R417 - R430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Laurent, L. Jaubert-Miazza, R. Desjardins, R. Day, and I. Lindberg
Biosynthesis of Proopiomelanocortin-Derived Peptides in Prohormone Convertase 2 and 7B2 Null Mice
Endocrinology,
February 1, 2004;
145(2):
519 - 528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mayan, X.-P. Ni, S. Almog, and M. H. Humphreys
Suppression of {gamma}-Melanocyte-Stimulating Hormone Secretion Is Accompanied by Salt-Sensitive Hypertension in the Rat
Hypertension,
November 1, 2003;
42(5):
962 - 967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. TAYLOR, W. J. M. VAN DE VEN, and J. W. M. CREEMERS
Curbing activation: proprotein convertases in homeostasis and pathology
FASEB J,
July 1, 2003;
17(10):
1215 - 1227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Inoue, T. Kawashima, R. G. Allen, and H. Ueda
Nocistatin and Prepro-Nociceptin/Orphanin FQ 160-187 Cause Nociception through Activation of Gi/o in Capsaicin-Sensitive and of Gs in Capsaicin-Insensitive Nociceptors, Respectively
J. Pharmacol. Exp. Ther.,
July 1, 2003;
306(1):
141 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|